Skip to content

KMTS KMTS Capital Contribution From West Affum LP To Settle Warrant Obligation

Capital Contribution From West Affum LP To Settle Warrant Obligation at other companies

GCM Grosvenor Inc. logo
GCM Grosvenor Inc.GCMG
$0-100%
Replimune Group logo
Replimune GroupREPL
$0-100%
Satellogic logo
SatellogicSATL
$0-100%
XER
Xeris Biopharma Holdings, Inc.XERS
$7.33M
Esperion Therapeutics logo
Esperion TherapeuticsESPR
$16.22M
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
$1.26M

Other financials

Income statement

See full
Revenue$24.6M+62.7%
Gross profit$12.9M+97.1%
Operating income-$34.8M-68.8%
Net income-$34.2M-58.8%
EPS (diluted)-$0.61+51.2%

Balance sheet

See full
Cash & equivalents$291.3M+436%
Total debt$43.8M
Total assets$379.3M

Cash flow

See full
Operating cash flow-$18.4M-2.1%
CapEx$9.8M+141%
Free cash flow-$28.2M-27.7%

Valuation

See full
Market cap$1.32B+70.8%
Enterprise value$1.07B
P/S15.7×

Profitability

See full
Gross margin48.8%+15.1pp
Operating margin-171.5%+12.9pp
Net margin-173%+0.8pp
FCF margin-142.9%-25.3pp

Returns & leverage

See full
Current ratio7.3×

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept ck0001877184:CapitalContributionFromWestAffumLPToSettleWarrantObligation.

The official record: KMTS’s 10-K, filed July 17, 2025, on SEC EDGAR. View the filing →

Ask your AI about KMTS's capital contribution from west affum lp to settle warrant obligation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KMTS's capital contribution from west affum LP to settle warrant obligation?
KMTS (KMTS) reported capital contribution from west affum LP to settle warrant obligation of $408K in Q1 2024.
What does capital contribution from west affum LP to settle warrant obligation mean?
Represents specific capital injections provided by a strategic partner to satisfy or settle outstanding warrant obligations. This metric tracks non-dilutive or specific-purpose funding that supports the company's balance sheet health. It serves as an indicator of external support for managing complex financial instruments.